Skip to main content

Table 1 Overview of independent SNPs reaching at least suggestive significance in our GWAMA

From: Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis

 

Cytoband

Independent SNP

EAF

Beta

p-value

Expl Var (%)

Best subgroup

Nearest/candidate gene (kb)

Known loci

1p32.3

rs11591147

0.015

− 0.372

1.70 × 10–144

4.32

Free

PCSK9 (0)

rs693668

0.633

0.052

7.80 × 10–39

1.51

M

PCSK9 (0)

rs11583680

0.139

− 0.051

3.98 × 10–20

0.76

M

PCSK9 (0)

rs2495491

0.756

− 0.039

5.01 × 10–20

0.56

Free

PCSK9 (6.8)

2p24.1

rs1367117

0.314

− 0.029

2.09 × 10–15

0.42

Free

APOB (3.3)

10q21.3

rs10740131

0.481

0.018

1.44 × 10–07

0.19

Free

JMJD1C (46)

11q12.2

rs174535

0.331

0.022

1.49 × 10–09

0.25

Free

FADS1 (16)

16q22.2

rs34042070

0.204

0.023

8.43 × 10–08

0.19

Free

HPR (0), HP (6.6)

19p13.11

rs8107974

0.087

− 0.040

5.76 × 10–11

0.29

Free

TM6SF2 (4.3)

Novel loci

6q11.1

rs3076276

0.111

− 0.079

2.31 × 10–08

1.22

Treated

KHDRBS2 (0)

7q36.1

rs34924001

0.360

0.037

4.45 × 10–07

0.51

M—free

PRKAG2 (0)

10q11.21

rs76849715

0.050

0.058

6.52 × 10–08

0.38

M—free

MARCHF8 (0), ALOX5 (140)

12p12.2

rs4762806

0.058

− 0.077

3.44 × 10–07

0.56

W—free

SLCO1B3 (0)

12q24.22

rs4767549

0.405

− 0.022

1.41 × 10–08

0.29

M

KSR2 (0), NOS1 (60)

  1. For each locus, we report here the genomic cytoband, beta estimate, p-value and explained variance of the best-associated SNP in the best-associated subgroup. The loci are first ordered by novelty (first 6 loci: known, last 5 loci: novel), and then by chromosomal position via cytobands. For PCSK9 only, we report the four independent variants as detected by the conditional-joint analyses. Candidate genes are defined as nearest gene or other plausible gene as identified in literature review or co-localization analyses. The distance between lead SNP and candidate gene is given in kb. Bold written genes indicate positive co-localization of the PCSK9 signal and the expression of the candidate gene in at least one tissue (PP H4 ≥ 0.75). EAF: effect allele frequency; Free: statin-free subgroup (sex-combined); Treated: statin-treated subgroup (sex-combined); M: subgroup of men (statin-combined); M-Free: subgroup of statin-free men; W-Free: subgroup of statin-free women